Publications by authors named "Han Cun"

Claim this Profile
R
Radiation therapy for the gynecologic oncologist.
Han T Cun, Sabrina M Bedell, John Kimball, David K Gaffney, Yasmin Hasan

Gynecol Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Growing Interest in Global Health Among Trainees: The Need for Increasing Training Opportunities for Residents and Fellows in Oncology.
Darya Kizub, Chidinma P Anakwenze, Han Cun, Kathleen M Schmeler, Cameron E Gaskill

Glob Health Epidemiol Genom· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive molecular characterization of early stage grade 3 endometrioid endometrial adenocarcinoma.
Han T Cun, Laurence Bernard, Karin Teien Lande, Barrett C Lawson, Anne-Jorunn Nesbakken

Gynecol Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive Review of Uterine Leiomyosarcoma: Pathogenesis, Diagnosis, Prognosis, and Targeted Therapy.
Qiwei Yang, Obianuju Sandra Madueke-Laveaux, Han Cun, Marta Wlodarczyk, Natalia Garcia

Cells· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isolated vaginal recurrence in women with stage I endometrial cancer.
Eric Rios-Doria, Han T Cun, Olga T Filippova, Jennifer J Mueller, Kaled M Alektiar

Gynecol Oncol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exceptional Response to Pembrolizumab for Treatment of Metastatic Chemorefractory Endometrial Carcinoma in a Patient with Lynch Syndrome: A Case Report.
Samantha Batman, J Alejandro Rauh-Hain, Michaela Onstad Grinsfelder, Ross Harrison, Monica Avila, Han Cun

Case Rep Oncol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of Peritoneal Carcinomatosis After Risk-Reducing Salpingo-Oophorectomy: A Systematic Review and Individual Patient Data Meta-Analysis.
Miranda P Steenbeek, Majke H D van Bommel, Johan Bulten, Julia A Hulsmann, Joep Bogaerts, Han T Cun

J Clin Oncol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Hu, W., et al. Targeting Dopamine Receptor D2 by Imipridone Suppresses Uterine Serous Cancer Malignant Phenotype. 2020, , 2436.
Wen Hu, Li Zhang, Sammy Ferri-Borgogno, Suet-Ying Kwan, Kelsey E Lewis, Han T Cun

Cancers (Basel)· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting Dopamine Receptor D2 by Imipridone Suppresses Uterine Serous Cancer Malignant Phenotype.
Wen Hu, Li Zhang, Sammy Ferri-Borgogno, Suet-Ying Kwan, Kelsey E Lewis, Han T Cun

Cancers (Basel)· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unanswered Questions in High-Risk Women Undergoing Risk-Reducing Salpingo-oophorectomy.
Han T Cun, Karen H Lu

Obstet Gynecol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis